Dabigatran - Intermediate
Name of Intermediate: Ethyl 3-(2-Pyridylamino)propionate
Name of API: Dabigatran
CAS No: 103041-38-9
Our Dabigatran intermediates are developed to meet stringent global standards for Active Pharmaceutical Ingredients (APIs). Manufactured using advanced synthesis routes and precise quality control, they enable efficient, high-yield production of Dabigatran. With scalable and reproducible processes, we ensure consistent purity and stability from lab-scale development to commercial manufacturing. Each intermediate is optimized for process efficiency, regulatory compliance, and reliable performance in formulation. Partnering with SSPharma gives you access to high-quality Dabigatran intermediates that support faster development cycles, robust supply chains, and seamless transition from R&D to large-scale production — empowering innovation in diabetes therapeutics.
Name of Intermediate: Ethyl 3-(2-Pyridylamino)propionate
Name of API: Dabigatran
CAS No: 103041-38-9
Name of Intermediate: N-(4-Cyanophenyl)glycine
Name of API: Dabigatran
CAS No: 42288-26-6
Name of Intermediate: Ethyl 3-[3-Amino-4-(methylamino)-N-(2-pyridyl)benzamido]propionate
Name of API: Dabigatran
CAS No: 212322-56-0
Name of Intermediate: 4-Aminobenzonitrile
Name of API: Dabigatran
CAS No: 873-74-5
Name of Intermediate: Hexyl ((4-Aminophenyl)(imino)methyl)carbamate Hydrochloride
Name of API: Dabigatran
CAS No: 1307233-93-7
Name of Intermediate: Dabigatran Etexilate
Name of API: Dabigatran
CAS No: 211915-06-9
Name of Intermediate: N-[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine Ethyl Ester
Name of API: Dabigatran
CAS No: 211915-84-3